Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Aplodan (creatinol-O-phosphate) exhibits antiischemic and antiarrhythmic capacity and protective action on the cell membrane. Aplodan can be used in research on the ischemic heart or ischemic heart disease with persistent ventricular premature beats.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
25 mg | 在庫あり | ¥ 10,000 | |||
50 mg | 在庫あり | ¥ 15,500 | |||
100 mg | 在庫あり | ¥ 21,500 | |||
200 mg | 在庫あり | ¥ 31,500 | |||
500 mg | 在庫あり | ¥ 55,000 |
説明 | Aplodan (creatinol-O-phosphate) exhibits antiischemic and antiarrhythmic capacity and protective action on the cell membrane. Aplodan can be used in research on the ischemic heart or ischemic heart disease with persistent ventricular premature beats. |
別名 | Nergize, Creatinolfosfate, creatinol-O-phosphate, Creatinolfosfate, Creatinol Phosphate |
分子量 | 197.13 |
分子式 | C4H12N3O4P |
CAS No. | 6903-79-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Slightly soluble
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Aplodan 6903-79-3 Others antiischemic antiarrhythmic Nergize VPB Creatinolfosfate cell membrane inhibit ventricular premature beat ischemic heart Creatinol creatinol-O-phosphate Creatinol O-phosphate Inhibitor Creatinolfosfate, Creatinol Phosphate inhibitor